documents: FDA-2022-D-1261-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-1261-0003 FDA FDA-2022-D-1261 Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability Notice Notice of Availability 2026-05-11T04:00:00Z 2026 5 2026-05-11T04:00:00Z   2026-05-11T17:42:11Z 2026-09267 0 0 09000064b92cf922

Links from other tables